simusolv modeling and simulation program (Dow Chemical)
90
Structured Review
Dow Chemical
simusolv modeling and simulation program
Simusolv Modeling And Simulation Program, supplied by Dow Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simusolv+program/simusolv+software/pm10366546-74-43-45
Average 90 stars, based on 1 article reviews
Simusolv Modeling And Simulation Program, supplied by Dow Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simusolv+program/simusolv+software/pm10366546-74-43-45
Average 90 stars, based on 1 article reviews
simusolv modeling and simulation program - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Software:Article Title: Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate. Article Snippet: Reference values, including an oral reference dose (RfD) and an inhalation reference concentration (RfC), were derived for propylene glycol methyl ether (PGME), and an oral RfD was derived for its acetate (PGMEA).. These values were based on transient sedation observed in F344 rats and B6C3F1 mice during a two-year inhalation study.. The dose-response relationship for sedation was characterized using internal dose measures as predicted by a physiologicallybased pharmacokinetic (PBPK) model for PGME and its acetate. Article Title: The impact of cytochrome P450 2E1-dependent metabolic variance on a risk-relevant pharmacokinetic outcome in humans. Article Snippet: Risk assessments include assumptions about sensitive subpopulations, such as the fraction of the general population that is sensitive and the extent that biochemical or physiological attributes influence sensitivity.. Uncertainty factors (UF) account for both pharmacokinetic (PK) and pharmacodynamic (PD) components, allowing the inclusion of risk-relevant information to replace default assumptions about PK and PD variance (uncertainty).. Large numbers of human organ donor samples and recent advances in methods to extrapolate in vitro enzyme expression and activity data to the intact human enable the investigation of the impact of PK variability on human susceptibility. Article Title: Development of a physiologically based pharmacokinetic model for propylene glycol monomethyl ether and its acetate in rats and humans. Article Snippet: Propylene glycol monomethyl ether (PM), along with its acetate, is the most widely used of the propylene glycol ether family of solvents.. The most common toxic effects of PM observed in animal studies include sedation, very slight alpha2u-globulin mediated nephropathy (male rats only) and hepatomegally at high exposures (typically > 1000 ppm).. Sedation in animal studies usually resolves within a few exposures to 3000 ppm (the highest concentration used in subchronic and chronic inhalation studies) due to the induction of metabolizing enzymes. Article Title: Evaluation of the dermal bioavailability of aqueous xylene in F344 rats and human volunteers. Article Snippet: Taylor & Francis makes every effort to ensure the accuracy of all the information (the “Content”) contained in the publications on our platform.. However, Taylor & Francis, our agents, and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content.. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. Article Title: Terrestrial field dissipation of diclosulam at four sites in the United States. Article Snippet: The soil dissipation of diclosulam was studied using 14C-labeled and nonradiolabeled material in Mississippi, North Carolina, Georgia, and Illinois between 1994 and 1997.. The test substance was preemergence broadcast applied at target rates of 35 and 37 g ai ha-1 for the 14C-labeled and the nonradiolabeled studies, respectively.. The degradation of diclosulam was rapid with half-lives ranging from 13 to 43 days at the four sites. Article Title: Evaluation of the dermal absorption of aqueous toluene in F344 rats using real-time breath analysis and physiologically based pharmacokinetic modeling. Article Snippet: This article was downloaded by: [Florida State University] On: 29 December 2014, At: 23:18 Publisher: Taylor & Francis Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK Journal of Toxicology and Environmental Health, Part A: Current Issues Publication details, including instructions for authors and subscription information: http://www.tandfonline.com/loi/uteh20 EVALUATION OF THE DERMAL ABSORPTION OF AQUEOUS TOLUENE IN F344 RATS USING REALTIME BREATH ANALYSIS AND PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING Karla D. Thrall a & Angela D. Woodstock a a Molecular Biosciences Department, Fundamental Science Division, Battelle, Pacific Northwest Laboratory, Richland, Washington, USA Published online: 07 Jan 2011.. To cite this article: Karla D. Thrall & Angela D. Woodstock (2002) EVALUATION OF THE DERMAL ABSORPTION OF AQUEOUS TOLUENE IN F344 RATS USING REAL-TIME BREATH ANALYSIS AND PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING, Journal of Toxicology and Environmental Health, Part A: Current Issues, 65:24, 2087-2100, DOI: 10.1080/00984100290071540 To link to this article: http://dx.doi.org/10.1080/00984100290071540 PLEASE SCROLL DOWN FOR ARTICLE Taylor & Francis makes every effort to ensure the accuracy of all the information (the “Content”) contained in the publications on our platform.. However, Taylor & Francis, our agents, and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. other:Article Title: Horizontal reactive distillation for multicomponent chiral resolution Article Snippet: A novel horizontal reactive distillation apparatus and a new overall process scheme are proposed for continuous multicomponent chiral resolution via reversible enantioselective acylation of a chiral (racemic) substrate by a chiral (racemic) acyl donor.. The process enables simultaneous production of up to four enantiomers with enhanced chiral purity.. Kinetic studies, miniplant experiments, and process simulation results are described for a model lipase-catalyzed reaction: (R)-enantioselective transesterification of (R,S)-1-n-butoxy-2-propanol with (R,S)-1-methoxy-2-acetoxypropane to produce (R)-1-nbutoxy-2-acetoxypropane, (R)-1-methoxy-2-propanol, and the two unreacted (S)-enantiomers of the (R,S)-reagents. In Vivo:Article Title: Development of a physiologically based pharmacokinetic model for methyl ethyl ketone in F344 rats. Article Snippet: This article was downloaded by: [University of Chicago Library] On: 14 November 2014, At: 11:35 Publisher: Taylor & Francis Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK Journal of Toxicology and Environmental Health, Part A: Current Issues Publication details, including instructions for authors and subscription information: http://www.tandfonline.com/loi/uteh20 DEVELOPMENT OF A PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR METHYL ETHYL KETONE IN F344 RATS Karla D. Thrall a , Jolen J. Soelberg a , Karl K. Weitz a & Angela D. Woodstock a a Molecular Biosciences Department, Fundamental Science Division, Battelle, Pacific Northwest Laboratory, Richland, Washington, USA Published online: 07 Jan 2011.. To cite this article: Karla D. Thrall , Jolen J. Soelberg , Karl K. Weitz & Angela D. Woodstock (2002) DEVELOPMENT OF A PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR METHYL ETHYL KETONE IN F344 RATS, Journal of Toxicology and Environmental Health, Part A: Current Issues, 65:13, 881-896, DOI: 10.1080/00984100290071207 To link to this article: http://dx.doi.org/10.1080/00984100290071207 PLEASE SCROLL DOWN FOR ARTICLE Taylor & Francis makes every effort to ensure the accuracy of all the information (the “Content”) contained in the publications on our platform.. However, Taylor & Francis, our agents, and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. |